These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16141258)

  • 1. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.
    Milliez P; Deangelis N; Rucker-Martin C; Leenhardt A; Vicaut E; Robidel E; Beaufils P; Delcayre C; Hatem SN
    Eur Heart J; 2005 Oct; 26(20):2193-9. PubMed ID: 16141258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.
    Chabot A; Jiang BH; Shi Y; Tardif JC; Dupuis J
    BMC Cardiovasc Disord; 2011 Dec; 11():72. PubMed ID: 22136321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of spironolactone alone and in addition to a β-blocker on myocardial histological and electrical remodeling in chronic severe failing rat hearts.
    Milliez P; Gomes S; Champ-Rigot L; Callebert J; Samuel JL; Delcayre C
    J Cardiovasc Pharmacol; 2012 Sep; 60(3):315-21. PubMed ID: 22710814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
    Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
    Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat.
    Leader CJ; Wilkins GT; Walker RJ
    PLoS One; 2021; 16(11):e0260554. PubMed ID: 34843581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat.
    Boixel C; Fontaine V; Rücker-Martin C; Milliez P; Louedec L; Michel JB; Jacob MP; Hatem SN
    J Am Coll Cardiol; 2003 Jul; 42(2):336-44. PubMed ID: 12875773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2003 Feb; 41(4):574-81. PubMed ID: 12598068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of spironolactone on atrial remodeling in patients with preserved left ventricular function after an acute myocardial infarction: a randomized follow-up study.
    Kayrak M; Bacaksiz A; Vatankulu MA; Ayhan SS; Ari H; Kaya Z; Ozdemir K
    Coron Artery Dis; 2010 Dec; 21(8):477-85. PubMed ID: 20926948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
    Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
    J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.
    Ramires FJ; Mansur A; Coelho O; Maranhão M; Gruppi CJ; Mady C; Ramires JA
    Am J Cardiol; 2000 May; 85(10):1207-11. PubMed ID: 10802002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy.
    Arumugam S; Sreedhar R; Karuppagounder V; Harima M; Nakamura M; Suzuki H; Sone H; Watanabe K
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28664677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction.
    Masson S; Staszewsky L; Annoni G; Carlo E; Arosio B; Bai A; Calabresi C; Martinoli E; Salio M; Fiordaliso F; Scanziani E; Rudolph AE; Latini R
    J Card Fail; 2004 Oct; 10(5):433-41. PubMed ID: 15470655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
    Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone improves the arrhythmogenic substrate in heart failure by preventing ventricular electrical activation delays associated with myocardial interstitial fibrosis and inflammation.
    Esposito CT; Varahan S; Jeyaraj D; Lu Y; Stambler BS
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):806-12. PubMed ID: 23489714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.